Meningococcal Vaccines Market Expected to Reach USD 4.4 Billion Globally in 2022: Transparency Market Research
15 avr. 2015 07h32 HE
|
Transparency Market Research
Albany, NY, April 15, 2015 (GLOBE NEWSWIRE) -- Meningococcal disease is caused by the bacterium
Neisseria meningitidis and occurs sporadically throughout the world
with seasonal variations. It...